Meta facebook tracking pixel

Program Status:  

Closed

Unfortunately, this fund is currently closed. Funds will open and close periodically throughout the year, so please check our website frequently for the most up-to-date fund status.

To receive an email notification when this fund re-opens, click the register button below.

Register to receive email notification when fund re-opens

Eligibility Criteria

Diagnosis:
• Metastatic pheochromocytoma and paraganglioma ICD-10 codes are C74.10, C74.11, C74.12 and D44.7 w/metastatic disease. View list of ICD-10 codes »
• Primary cancer diagnosis must be the same as the fund and verified by the prescribing physician. Download Physician Verification Form »

Insurance:
• Patient must be insured through a federal health insurance program such as Medicare, Medicaid or TRICARE

Income:
• Income level must be at or below 500% of the Federal Poverty Level (FPL)

Citizenship:
• Must have a valid Social Security number to apply for assistance and receive treatment in the United States

Treatments Covered:
• Patient must be in active treatment or have a treatment plan in place prior to applying for assistance. Read more in our FAQs »

Initial Grant Amount

$10,000

Program CAP Amount

$15,000

If the initial grant amount is exhausted before the grant end date, a request for additional funds up to the program CAP amount can be submitted. Read our Request for Additional Funds policy »

Retroactive policy

CCAF will consider retroactive reimbursement on a case-by-case basis for first time applicants actively receiving a covered treatment. Our retroactive assistance will only consider dates of service within 60 days prior to the date we approve the application. Conditional approvals are not eligible for retroactive coverage.

Additional Services

CancerCare offers support services for people with Metastatic Pheochromocytoma and Paraganglioma including counseling, support groups, financial assistance, workshops and publications.

View all services

« Back to Co-Payment Funding
Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.